STU-2026-089 — Phase III Oncology — Compound SYN-441
Locked. Locked 01 Apr 2026 20:18 UTC by [email protected]. Study setup is complete: no task can be changed, and a task can only be added against a protocol amendment, by the catalog owner. A task whose meaning must change is added under a new code and the old one retired.
| Code | Task | Roles | Added | Source | Status |
|---|---|---|---|---|---|
| TASK-001 |
Informed Consent Process Required Obtain and document subject informed consent. |
Principal Investigator, Sub-Investigator, Clinical Research Coordinator | 22 Mar 2026 20:18 UTC by SYSTEM | Study setup | Active |
| TASK-002 |
Eligibility Assessment Required Confirm inclusion and exclusion criteria. |
Principal Investigator, Sub-Investigator | 22 Mar 2026 20:18 UTC by SYSTEM | Study setup | Active |
| TASK-003 |
Investigational Product Accountability Receipt, storage, dispensing and reconciliation of IP. |
Principal Investigator, Clinical Research Coordinator | 22 Mar 2026 20:18 UTC by SYSTEM | Study setup | Active |
| TASK-004 |
Source Data Entry Record source data and complete eCRFs in the EDC. |
Clinical Research Coordinator | 22 Mar 2026 20:18 UTC by SYSTEM | Study setup | Active |
| TASK-005 |
Adverse Event Assessment Required Assess causality and severity of adverse events. |
Principal Investigator, Sub-Investigator | 22 Mar 2026 20:18 UTC by SYSTEM | Study setup | Active |
| TASK-006 |
Protocol Deviation Reporting Identify, document and report protocol deviations. |
Principal Investigator, Sub-Investigator, Clinical Research Coordinator, Clinical Research Associate / Monitor, Clinical Trial Manager | 22 Mar 2026 20:18 UTC by SYSTEM | Study setup | Active |
| TASK-007 |
Sample Collection & Processing Collect, process and ship biological samples. |
Clinical Research Coordinator | 22 Mar 2026 20:18 UTC by SYSTEM | Study setup | Active |
The catalog is managed by the study's Task Catalog Owner, who signs in to change it.